MedTrace Logo

Liver Biomarkers in Anorexia Nervosa

NCT05861375 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 43

Last updated 2026-04-17

No results posted yet for this study

Summary

The main goal of the Liver Biomarkers in Anorexia Nervosa (LIBAN) study is to determine the prevalence of liver fibrosis in patient with Anorexia Nervosa.

Conditions

  • Anorexia Nervosa

Interventions

DIAGNOSTIC_TEST

Fibroscan

Fibroscan is a non-invasive device that allows liver exploration painlessly, quickly (a few minutes) and with immediate results. A probe placed on the skin generates an elastic wave completely painlessly and the device measures its speed of propagation in the liver. Liver stiffness is calculated from this speed.

Sponsors & Collaborators

  • Nantes University Hospital

    lead OTHER

Principal Investigators

  • Sarra SMATI-GRANGEON, PH · Nantes University Hospital

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-23
Primary Completion
2025-06-27
Completion
2025-06-27

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05861375 on ClinicalTrials.gov